Johan Linderoth

Evaluation of immunophenotype in diffuse large B-cell lymphoma and its impact on prognosis

Mattias Berglund, Ulf Thunberg, Rose‐Marie Amini et al. · Modern Pathology · 2005 · 202 citations · Full text

Hematological Malignancy, Lymphoid Neoplasia, Autoimmune Disease +10

Immunohistochemical expression of CD23 and CD40 may identify prognostically favorable subgroups of diffuse large B-cell lymphoma: a Nordic Lymphoma Group Study.

Johan Linderoth, Mats Jerkeman, Eva Cavallin‐Ståhl et al. · PubMed · 2003 · 103 citations

Protein expression and cellular localization in two prognostic subgroups of diffuse large B-cell lymphoma: Higher expression of ZAP70 and PKC-β II in the non-germinal center group and poor survival in patients deficient in nuclear PTEN

Marie Fridberg, Anna Servin, Lola Anagnostaki et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2007 · 54 citations · Full text

A Subset of CD5– Diffuse Large B-Cell Lymphomas Expresses Nuclear Cyclin D1 With Aberrations at the<i>CCND1</i>Locus

Mats Ehinger, Johan Linderoth, Birger Christensson et al. · American Journal of Clinical Pathology · 2008 · 46 citations · Full text

Hematological Malignancy, Tumor Biology, Structural Aberrations +15

Sick leave and disability pension in Hodgkin lymphoma survivors by stage, treatment, and follow-up time—a population-based comparative study

Ingrid Glimelius, Sara Ekberg, Johan Linderoth et al. · Journal of Cancer Survivorship · 2015 · 41 citations

Disability Pension, Health Policy, Medicine +8